Cargando…
Multiple Myeloma Associated Bone Disease
The lytic bone disease is a hallmark of multiple myeloma, being present in about 80% of patients with newly diagnosed MM, and in more during the disease course. The myeloma associated bone disease (MBD) severely affects the morbidity and quality of life of the patients. MBD defines treatment demandi...
Autores principales: | Rasch, Stine, Lund, Thomas, Asmussen, Jon Thor, Lerberg Nielsen, Anne, Faebo Larsen, Rikke, Østerheden Andersen, Mikkel, Abildgaard, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465468/ https://www.ncbi.nlm.nih.gov/pubmed/32751464 http://dx.doi.org/10.3390/cancers12082113 |
Ejemplares similares
-
Vertebroplasty in patients with multiple myeloma with vertebral compression fractures: protocol for a single-blind randomised controlled trial
por: Wickstroem, Line Adsboell, et al.
Publicado: (2021) -
Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma—a randomized controlled feasibility study
por: Larsen, Rikke Faebo, et al.
Publicado: (2019) -
Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
por: Larsen, Rikke Faebo, et al.
Publicado: (2020) -
Potential value of pre-planned imaging of bone disease in multiple myeloma
por: Gundesen, Michael T., et al.
Publicado: (2023) -
P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW.
por: Gundesen, Michael, et al.
Publicado: (2023)